What is Short Bowel Syndrome?
Short Bowel Syndrome (SBS) is a malabsorptive condition that occurs when a significant portion of the small intestine is missing or nonfunctional. In children, the loss of intestinal length can be congenital or acquired after surgery for conditions such as necrotizing enterocolitis, intestinal atresia, volvulus, or trauma.
The remaining bowel must adapt to absorb nutrients, electrolytes, and fluids sufficient for growth and development. The degree of adaptation varies widely and depends on the length of residual small intestine, the presence of the ileum and colon, and the childs overall health.
Causes & Risk Factors
- Necrotizing enterocolitis (NEC): The most common cause in premature infants; often requires resection of necrotic segments.
- Intestinal atresia or stenosis: Congenital blockage that may need surgical correction.
- Midgut volvulus: Twisting of the intestine leading to ischemia and possible resection.
- Traumatic injury or abdominal surgery: Accidental loss of bowel during procedures.
- Intrauterine vascular accidents: Rare, but can lead to shortened bowel at birth.
Risk is higher in premature infants, those with low birth weight, and children who have multiple abdominal surgeries.
Signs & Symptoms
Because the small intestine is the primary site for nutrient absorption, children with SBS often present with:
- Persistent watery or fatty stools (steatorrhea)
- Failure to thrive or poor weight gain
- Dehydration and electrolyte disturbances
- Vomiting, especially after feeds
- Abdominal bloating and discomfort
- Frequent hospitalizations for infections or metabolic imbalances
Symptoms may evolve as the remaining bowel adapts; some children gradually require fewer interventions over time.
Diagnosis
Diagnosis is clinical, supported by imaging and laboratory studies:
| Investigation | Purpose |
|---|---|
| Abdominal Xray / Contrast studies | Assess anatomy, identify strictures or leaks |
| Ultrasound / MRI | Evaluate bowel thickness, vascular supply |
| Stool fat quantification | Measure malabsorption severity |
| Serum electrolytes, albumin, prealbumin | Monitor nutritional status |
| Growth charts | Track weight, length/height, head circumference |
The residual length of small intestine is usually measured during surgery; functional length may be longer if the colon is intact.
Management Strategies
Management is multidisciplinary and focuses on maximizing nutrition, preventing complications, and supporting growth.
1. Nutritional Therapy
- Enteral Nutrition (EN): Preferred whenever possible. Formula composition is tailored to promote intestinal adaptation highprotein, mediumchain triglycerides, and lowosmolar feeds.
- Parenteral Nutrition (PN): Required when EN cannot meet needs. Central venous catheter care is critical to prevent bloodstream infections.
- Hybrid approaches: Cyclical PN combined with progressive EN to wean off intravenous support.
2. Medications
- Antidiarrheal agents: Loperamide or diphenoxylateatropine to reduce stool output.
- Proton pump inhibitors: Decrease gastric hypersecretion that can worsen diarrhea.
- GLP2 analogs (e.g., teduglutide): Promote mucosal growth and improve absorption in selected patients.
- Vitamin & Mineral Supplements: Fatsoluble vitamins (A, D, E, K), calcium, iron, zinc, and trace elements.
3. Surgical Options
- Intestinal lengthening procedures: Serial transverse enteroplasty (STEP) or longitudinal intestinal lengthening and tailoring (LILT) can increase absorptive surface.
- Intestinal transplantation: Considered for children with irreversible liver disease from PN or lifethreatening PN complications.
4. Monitoring & Complication Prevention
- Regular growth assessments every 13 months.
- Frequent liver function tests longterm PN can cause PNassociated liver disease.
- Catheter care protocols to reduce infection risk.
- Bone density evaluation for chronic vitamin D deficiency.
Prognosis & Outlook
Outcomes have improved dramatically over the past two decades. Approximately 7080% of infants with SBS achieve enteral autonomy (no longer need PN) by age 35 years, especially when the colon is present and the residual bowel length exceeds 40cm. Factors associated with poorer prognosis include:
- Very short residual small intestine (<30cm)
- Absence of the ileocecal valve and colon
- Severe liver disease from prolonged PN
- Recurrent catheterrelated infections
Longterm followup is essential. Children who wean off PN still require dietary counseling, monitoring for micronutrient deficiencies, and periodic assessment for growth delays.
